Showing 12 of 29 posts with this tag
On April 6, Airbus, a European aircraft manufacturer, announced that it had signed an agreement with a Chinese partner to purchase 160 commercial aircraft. As part of the expansion into the country, Airbus will also be opening a second assembly line in Tianjin.
Foxconn, the Taiwan-based leading iPhone assembler, issued a statement at midday on October 26 saying that "reports of 20,000 people diagnosed with COVID-19 at the Zhengzhou Industrial Park, Henan Province" circulating online were "seriously false information."
In this op-ed, tuzhuxi argues that Hong Kong lacks the necessary political, social and cultural foundations to execute the “Dynamic Zero-Covid” strategy, and meanwhile it dares not perform the “lying flat” policy to coexist with the virus.
The "false negative COVID results" of Lanzhou Nucleus Gene Huaxi pulled by the Shenzhen-based nucleic acid testing company and its actual controller Zhang Hezi from behind the scenes to the front and center.
On the evening of December 13, Fosun Pharma, the exclusive commercial partner of Chinese COVID-19 oral drug Azvudine, confirmed that the pills can soon be prescribed through online medical platforms.
Gotin, an online activity platform, recently completed a Pre-A round of financing. This round of funding was led by GL Ventures and followed by MSA Capital, Jinshajiang Venture Capital, and Picus.
Recently, Chinese nucleic acid testing companies have been controversial and accused of making huge profits during the COVID-19 pandemic. Among them, a company called Nucleus Gene has aroused widespread public doubts.
Many places across China are now facing a dramatic spike in COVID-19 infections. Due to the increasing number of patients with severe symptoms, market demand for drugs such as Paxlovid and Azvudine has soared.
Recent weeks have seen soaring COVID-19 cases across China, pushing many people to various domestic health platforms in an attempt to purchase coveted antiviral medication and fever-reduction pills.
With the recent lifting of pandemic control policies in China, the number of infections has risen sharply. Chinese internet giant Tencent launched a "COVID-19 Pills Mutual Help Public Welfare Platform."
Many local authorities in China have successively issued new pandemic prevention measures in the last two days, reducing the frequency of nucleic acid testing and advocating for more antigen tests. This has triggered an increase in demand among Chinese consumers for antigen test kits, and resources are now in short supply.
On December 13, the online COVID-19 Clinic of a Chinese internet hospital under 111, Inc., a domestic digital healthcare platform, began to pre-sell Paxlovid (nirmatrelvir tablets; ritonavir tablets), an oral antiviral drug for COVID-19. However, shortly after the news was reported, the drug was quickly removed from online platforms.